Skip to main content
Caplight Logo









Omic.ai

Omic.ai

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://omic.ai/

Company Overview

Omic.ai is a biotechnology company that provides an AI-driven digital patient and multi-omics drug discovery platform for target identification, biomarker discovery, and generative compound screening.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, ML Platforms, Clinical Trials, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Revenue Share, Services & Consulting, Freemium

AI Layer

Application

Keywords

AI drug discoverydrug discovery platformAI scientistautonomous AI agentsdigital patient modelsdrug target identificationdigital twinsgenerative chemistrymulti-omics analysisgenerative biologyvirtual clinical trialsin-silico trialsin-silico biotechcomputational biologyAI drug pipelinedrug asset licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Omic.ai Comparables

Compare Omic.ai with similar companies based on industry and business-model similarity.

Omic.ai comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Insilico Medicine
82%
Cellworks Group Inc
81%
Deep Origin
80%

Omic.ai Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Gabriel Richman

Founder And CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 15, 2025

    Grew 100% QoQ from 13 to 26 employees.

  • Jan 17, 2025

    Grew 100% QoQ from 12 to 24 employees.

Omic.ai Filings

Explore SEC and related filing metadata, where available.

Omic.ai filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Omic.ai's valuation, stock price, and market status.

Is Omic.ai a public or private company?

Omic.ai is a private company.

What is the current stock price of Omic.ai?

Omic.ai is a private company with no public stock price. Caplight tracks Omic.ai's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Omic.ai worth (valuation)?

Valuation information for Omic.ai is not publicly available.

Can I buy Omic.ai stock?

Omic.ai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Omic.ai's last funding round?

Funding round information for Omic.ai is not publicly available.

Who are the main investors in Omic.ai?

Investor information for Omic.ai is not publicly disclosed.

Will Omic.ai IPO soon?

No public IPO plans have been announced for Omic.ai.

How can I track Omic.ai secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Omic.ai's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range28
Year Founded2017
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?